Do extracellular chaperone proteins in plasma have potential as Alzheimer's disease biomarkers?
Madhav
M
Thambisetty
D000375:Aging / Q000097:blood; D000544:Alzheimer Disease / Q000097:blood* / Q000175:diagnosis* / Q000209:etiology / Q000378:metabolism / Q000628:therapy; D015415:Biomarkers / Q000097:blood / Q000134:cerebrospinal fluid / Q000378:metabolism; D051152:Clusterin / Q000097:blood; D018260:Gelsolin / Q000097:blood; D006242:Haptoglobins / Q000378:metabolism; D006801:Humans; D018832:Molecular Chaperones / Q000097:blood* / Q000134:cerebrospinal fluid / Q000378:metabolism; D011499:Protein Processing, Post-Translational / Q000502:physiology; D000683:Serum Amyloid P-Component / Q000378:metabolism; D000511:alpha-Macroglobulins / Q000378:metabolism
D015415:Biomarkers; C495242:CLU protein, human; D051152:Clusterin; D018260:Gelsolin; D006242:Haptoglobins; D018832:Molecular Chaperones; D000683:Serum Amyloid P-Component; D000511:alpha-Macroglobulins